FXAIX
Price
$263.06
Change
+$4.33 (+1.67%)
Updated
Jun 15 closing price
Net Assets
832.15B
VNSAX
Price
$24.41
Change
+$0.39 (+1.62%)
Updated
Jun 15 closing price
Net Assets
565.98M
Interact to see
Advertisement

FXAIX vs VNSAX

Header iconFXAIX vs VNSAX Comparison
Open Charts FXAIX vs VNSAXBanner chart's image
FXAIX vs VNSAX Comparison Chart in %
View a ticker or compare two or three
VS
FXAIX vs. VNSAX commentary
Jun 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a Buy and VNSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 832B vs. VNSAX (566M). FXAIX pays higher dividends than VNSAX: FXAIX (1.03) vs VNSAX (0.00). FXAIX was incepted earlier than VNSAX: FXAIX (15 years) vs VNSAX (14 years). VNSAX (1.09) is less costly to investors than FXAIX (0.01). VNSAX is a more actively managed with annual turnover of: 64.00 vs. FXAIX (3.00). FXAIX has a lower initial minimum investment than VNSAX: FXAIX (0) vs VNSAX (2500). FXAIX annual gain was more profitable for investors over the last year : 25.82 vs. VNSAX (10.18). FXAIX return over 5 years is better than : 88.95 vs. VNSAX (6.33).
FXAIXVNSAXFXAIX / VNSAX
Total Expense Ratio0.011.091%
Annual Report Gross Expense Ratio0.011.091%
Fund Existence15 years14 years-
Gain YTD9.1457.041130%
Front LoadN/A6%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets832B566M146,996%
Annual Yield % from dividends1.030.00-
Returns for 1 year25.8210.18254%
Returns for 3 years75.3929.28258%
Returns for 5 years88.956.331,405%
Returns for 10 years297.7067.58440%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TXMD2.290.09
+4.09%
TherapeuticsMD
KLIC115.432.30
+2.04%
Kulicke and Soffa Industries
GOLD43.66-0.57
-1.29%
Gold.com Inc.
PCYO10.57-0.16
-1.49%
Pure Cycle Corp
GSK52.23-0.81
-1.53%
GSK plc